The effectiveness of the complete health improvement program (CHIP) in Australasia for reducing selected chronic disease risk factors: A feasibility study

New Zealand Medical Journal

Volumn 126, Issue 1370, 2013, Pages

  Morton, Darren P ^a   Rankin, Paul ^a   Morey, Peter ^a   Kent, Lillian ^a   Hurlow, Trevor ^b   Chang, Esther ^c   Diehl, Hans ^d  

^a AVONDALE COLLEGE OF HIGHER EDUCATION   (Australia)

^b Southcare   (New Zealand)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

^d Lifestyle Medicine Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; BODY MASS; CALORIC INTAKE; CHRONIC DISEASE; CLINICAL TRIAL; COMPLETE HEALTH IMPROVEMENT PROGRAM; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEASIBILITY STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NUTRITION; PSYCHOLOGY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WEIGHT CHANGE;

EID: 84874596811     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Australian Institute for Health and Welfare. Key indicators of progress for chronic disease and associated determinants: data report; Cat. no. PHE 142. Canberra: AIHW; 2011.
2. Egger GJ, Binns AF, Rossner SR. The emergence of "lifestyle medicine" as a structured approach for management of chronic disease. Med J Aus 2009;190(3):143-145.
3. Diehl HA. Coronary risk reduction through intensive community-based lifestyle intervention: the CHIP experience. Am J of Cardiol 1998;82:83T-87T.
4. Englert HS, Diehl HA, Greenlaw RL, et al. The effect of a community-based coronary risk reduction: The Rockford CHIP. Prevent Med 2007;44:513-519.
5. Rankin P, Morton DP, Diehl H, et al. Effectiveness of a volunteer delivered lifestyle modification program for reducing cardiovascular disease risk factors. Am J of Cardiol 2012;109(1):82-86.
6. Merrill RM, Taylor P, Aldana SG, et al. Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression. Nutrition 2008;24(4):314-321.
7. Thieszen C, Merrill R, Aldana S, et al. The Coronary Health Improvement Project (CHIP) for lowering weight and improving psychosocial health. Psychological Reports 2011;109(1):338-352.
8. CHIP Health. www.chiphealth.com accessed 28th December 2011.
9. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
10. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998;97:1837-1847.
11. Gould AL, Davies GM, Alemao E, et al. Cholesterol reduction yields clinical benefits: meta analysis including recent trials. Clin Ther 2007; 29:778-794.
12. Prochaska JO, Norcross JC. Stages of change. Psychotherapy 2001;38(4):443-448.
13. Tang JL, Armitage JM, Lancaster T, et al. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ. 1998;316(7139):1213-1220.
14. Barnard ND, Gloede L, Cohen J, et al. A low-fat vegan diet elicits greater macronutrient changes, but is comparable in adherence and acceptability, compared with a more conventional diabetes diet among individuals with type 2 diabetes. J Am Diet Assoc 2009;109:263-272.
15. Ferdowsian, HR, Barnard ND. Effects of plant-based diets on plasma lipids. Am J Cardiol 2009;104:947-956.
16. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336(8708):129-133.
17. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
18. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England J Med 2002;346(6):Feb 7.
19. Esselstyn CB, Jr. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Am J Cardiol 1999;84:339-341, A338.
20. Anderson J, Ward K. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr 1979;32:2312-2321.
21. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes 1984;33:596-603.
22. Barnard R, Jung T, Inkeles S. Diet and exercise in the treatment of NIDDM. The need for early emphasis. Diabetes Care 1994;17:1469-1472.
23. Merrill RM, Aldana SG, Greenlaw RL, et al. Can newly acquired healthy behaviors persist? An analysis of health behavior decay. Prev Chronic Dis 2008;5(1):A13.
24. Lardizabal JA, Deedwania PC. Benefits of statin therapy and compliance in high risk cardiovascular patients. Vasc Health Risk Manag 2010;6:843-53.
25. Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11(14):1-160, iii-iv.
26. Kong BW. Community-based hypertension control programs that work. J Health Care Poor Underserved 1997;8:409-415.